U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BETIFISOLIMAB
INN  
Official Name English
MSB-2311
Preferred Name English
betifisolimab [INN]
Common Name English
MSB2311-HUMANIZED PD-L1 ANTIBODY
Common Name English
HUMANIZED PD-L1 ANTIBODY (MSB2311)
Common Name English
MSB2311
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-MUS MUSCULUS MONOCLONAL MSB2311 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MSB2311 .KAPPA.-CHAIN, DIMER
Common Name English
MSB 2311 [WHO-DD]
Common Name English
Code System Code Type Description
CAS
2460539-60-8
Created by admin on Wed Apr 02 13:50:08 GMT 2025 , Edited by admin on Wed Apr 02 13:50:08 GMT 2025
PRIMARY
FDA UNII
V7XRB4BO26
Created by admin on Wed Apr 02 13:50:08 GMT 2025 , Edited by admin on Wed Apr 02 13:50:08 GMT 2025
PRIMARY
INN
11926
Created by admin on Wed Apr 02 13:50:08 GMT 2025 , Edited by admin on Wed Apr 02 13:50:08 GMT 2025
PRIMARY
NCI_THESAURUS
C155931
Created by admin on Wed Apr 02 13:50:08 GMT 2025 , Edited by admin on Wed Apr 02 13:50:08 GMT 2025
PRIMARY
SMS_ID
300000042090
Created by admin on Wed Apr 02 13:50:08 GMT 2025 , Edited by admin on Wed Apr 02 13:50:08 GMT 2025
PRIMARY
ACTIVE MOIETY
BETIFISOLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966